WallStreetZenWallStreetZen

NASDAQ: BBIO
Bridgebio Pharma Inc Stock Ownership - Who owns Bridgebio Pharma?

Insider buying vs selling

Have Bridgebio Pharma Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Brian C. StephensonSecretary Treasurer CFO2024-05-1613,943$31.04
$432.79kSell
Neil KumarCEO and President2024-05-1630,748$31.04
$954.42kSell
Randal W. ScottDirector2024-03-012,500$34.00
$85.00kSell
Brian C. StephensonSecretary Treasurer CFO2024-02-1618,919$37.21
$703.98kSell
Neil KumarCEO and President2024-02-1647,922$37.21
$1.78MSell
Charles J. HomcyDirector2024-02-161,509$37.21
$56.15kSell
Hannah ValantineDirector2024-02-152,915$8.45
$24.63kBuy
Hannah ValantineDirector2024-02-152,915$37.75
$110.04kSell
Hannah ValantineDirector2024-01-162,915$8.45
$24.63kBuy
Hannah ValantineDirector2024-01-162,915$37.97
$110.68kSell

1 of 4

BBIO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BBIO insiders and whales buy or sell their stock.

BBIO Shareholders

What type of owners hold Bridgebio Pharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Kkr Group Partnership LP19.72%36,900,661$1.11BInsider
Kkr Genetic Disorder LP16.60%31,060,971$934.62MInsider
Kohlberg Kravis Roberts Co LP16.60%31,060,971$934.62MInstitution
Viking Global Performance LLC14.23%26,620,991$801.03MInsider
Viking Global Investors LP13.42%25,120,991$755.89MInsider
Viking Global Investors LP13.42%25,120,991$755.89MInstitution
Vanguard Group Inc7.07%13,222,126$397.85MInstitution
Blackrock Inc5.59%10,466,935$314.95MInstitution
Neil Kumar4.22%7,901,537$237.76MInsider
Aisling Capital Management LP3.24%6,068,125$182.59MInstitution

1 of 3

BBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BBIO56.56%43.44%Net SellingNet Selling
IONS96.26%3.74%Net SellingNet Buying
HALO77.92%22.08%Net SellingNet Selling
APLS74.59%25.41%Net BuyingNet Selling
MDGL23.83%76.17%Net BuyingNet Buying

Bridgebio Pharma Stock Ownership FAQ

Who owns Bridgebio Pharma?

Bridgebio Pharma (NASDAQ: BBIO) is owned by 91.05% institutional shareholders, 69.93% Bridgebio Pharma insiders, and 0.00% retail investors. Kkr Group Partnership LP is the largest individual Bridgebio Pharma shareholder, owning 36.90M shares representing 19.72% of the company. Kkr Group Partnership LP's Bridgebio Pharma shares are currently valued at $1.09B.

If you're new to stock investing, here's how to buy Bridgebio Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.